|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Kintara Therapeutics, Inc (KTRA) |
|
|
$0.08 0.00 (0.00%) as of 4:30 Fri 11/11
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
1,680,000 |
| Market
Cap: |
141.29(K) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.0841 - $0.0841 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Kintara Therapeutics is a clinical stage, biopharmaceutical company focused on the development and commercialization of new cancer therapies. Co.'s two primary candidates are: VAL-083, a validated, DNA-targeting agent, for the treatment of drug-resistant solid tumors such as glioblastoma multiforme and potentially other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a late-stage photodynamic therapy for the treatment of cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and access graft failure in hemodialysis patients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-14 |
2023-12-12 |
2023-06-13 |
2022-06-13 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bell John K |
Director |
– • – |
2016-12-31 |
4 |
A |
$3.20 |
$902 |
I/I |
282 |
35,006 |
|
- |
|
| Cranston Lynda Sarah |
Director |
– • – |
2016-12-31 |
4 |
A |
$3.20 |
$227 |
I/I |
71 |
190 |
|
- |
|
| Mohr Erich |
Director |
– • – |
2016-12-31 |
4 |
A |
$3.20 |
$1,690 |
D/D |
528 |
1,415 |
|
- |
|
| Brown Dennis M |
Chief Scientific Officer |
• • – |
2016-12-31 |
4 |
A |
$3.20 |
$541 |
I/I |
169 |
759,839 |
|
- |
|
| Bacha Jeffrey |
CEO |
• • – |
2016-12-31 |
4 |
A |
$3.20 |
$563 |
D/D |
176 |
34,969 |
|
- |
|
| Toth Robert Joseph Jr |
Director |
– • – |
2016-12-31 |
4 |
A |
$3.20 |
$237 |
D/D |
74 |
11,073 |
|
- |
|
| Bacha Jeffrey |
CEO |
• • – |
2016-10-03 |
4 |
A |
$3.20 |
$563 |
D/D |
176 |
34,793 |
|
- |
|
| Cranston Lynda Sarah |
Director |
– • – |
2016-10-03 |
4 |
A |
$3.20 |
$227 |
I/I |
71 |
119 |
|
- |
|
| Toth Robert Joseph Jr |
Director |
– • – |
2016-10-03 |
4 |
A |
$3.20 |
$237 |
D/D |
74 |
10,999 |
|
- |
|
| Brown Dennis M |
Chief Scientific Officer |
• • – |
2016-10-03 |
4 |
A |
$3.20 |
$541 |
I/I |
169 |
759,670 |
|
- |
|
| Bell John K |
Director |
– • – |
2016-10-03 |
4 |
A |
$3.20 |
$902 |
I/I |
282 |
34,724 |
|
- |
|
| Mohr Erich |
Director |
– • – |
2016-10-03 |
4 |
A |
$3.20 |
$1,690 |
D/D |
528 |
887 |
|
- |
|
| Praill Scott |
Chief Financial Officer |
• – – |
2016-10-03 |
4 |
A |
$3.20 |
$675 |
D/D |
211 |
15,355 |
|
- |
|
| Toth Robert Joseph Jr |
Director |
– • – |
2016-07-18 |
4 |
A |
$3.20 |
$160 |
D/D |
50 |
10,925 |
|
- |
|
| Praill Scott |
Chief Financial Officer |
• – – |
2016-07-18 |
4 |
A |
$3.20 |
$461 |
D/D |
144 |
15,144 |
|
- |
|
| Mohr Erich |
Director |
– • – |
2016-07-18 |
4 |
A |
$3.20 |
$1,149 |
D/D |
359 |
359 |
|
- |
|
| Bell John K |
Director |
– • – |
2016-07-18 |
4 |
A |
$3.20 |
$614 |
I/I |
192 |
34,442 |
|
- |
|
| Brown Dennis M |
Chief Scientific Officer |
• • – |
2016-07-18 |
4 |
A |
$3.20 |
$368 |
I/I |
115 |
759,501 |
|
- |
|
| Cranston Lynda Sarah |
Director |
– • – |
2016-07-18 |
4 |
A |
$3.20 |
$154 |
I/I |
48 |
48 |
|
- |
|
| Bacha Jeffrey |
CEO |
• • – |
2016-07-18 |
4 |
A |
$3.20 |
$384 |
D/D |
120 |
34,617 |
|
- |
|
| Bacha Jeffrey |
CEO, Director |
• • • |
2015-11-25 |
4 |
B |
$1.47 |
$11,025 |
D/D |
7,500 |
137,985 |
3.15 |
- |
|
| Bacha Jeffrey |
President, CEO |
• • • |
2015-10-08 |
4 |
B |
$0.78 |
$2,396 |
D/D |
3,000 |
130,485 |
3.15 |
- |
|
| Bacha Jeffrey |
President, CEO |
• • • |
2015-09-18 |
4 |
B |
$0.83 |
$3,320 |
D/D |
4,000 |
127,485 |
3.15 |
- |
|
| Brown Dennis M |
Chief Scientific Officer |
• • • |
2015-07-25 |
4 |
B |
$0.60 |
$6,000 |
I/I |
10,000 |
3,037,542 |
2.56 |
- |
|
| Bacha Jeffrey |
President, CEO |
• • • |
2015-07-25 |
4 |
B |
$0.60 |
$6,000 |
D/D |
10,000 |
123,485 |
3.15 |
- |
|
191 Records found
|
|
Page 6 of 8 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
